Protein,Protein_definition,Disease_category,Disease,Method,Nb_SNP,OR[95%CI],P_value
CALCB,Calcitonin gene-related peptide 2,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,Inverse variance weighted,9,1.01 [0.92-1.12],0.830007006869244
CALCB,Calcitonin gene-related peptide 2,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,Inverse variance weighted,9,1.00 [0.91-1.09],0.970995986574134
CALCB,Calcitonin gene-related peptide 2,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,Inverse variance weighted,9,0.99 [0.91-1.07],0.793773900584546
CALCB,Calcitonin gene-related peptide 2,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,Inverse variance weighted,9,3.08 [1.12-8.45],0.0292467170338652
CALCB,Calcitonin gene-related peptide 2,Chapter I Certain infectious and parasitic diseases,Other septicaemia,Inverse variance weighted,9,0.99 [0.85-1.15],0.89378399504329
CALCB,Calcitonin gene-related peptide 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,Inverse variance weighted,9,0.94 [0.80-1.11],0.478982974066907
CALCB,Calcitonin gene-related peptide 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",Inverse variance weighted,9,1.14 [0.87-1.49],0.3522330811658
CALCB,Calcitonin gene-related peptide 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,Inverse variance weighted,9,0.75 [0.31-1.83],0.533841890235747
CALCB,Calcitonin gene-related peptide 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,Inverse variance weighted,9,1.40 [1.02-1.93],0.0383444522341023
CALCB,Calcitonin gene-related peptide 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,Inverse variance weighted,9,0.89 [0.78-1.02],0.0992762529009326
CALCB,Calcitonin gene-related peptide 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",Inverse variance weighted,9,1.02 [0.84-1.24],0.850676499783083
CALCB,Calcitonin gene-related peptide 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,Inverse variance weighted,9,0.83 [0.60-1.14],0.254600817344969
CALCB,Calcitonin gene-related peptide 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,Inverse variance weighted,9,1.04 [0.66-1.64],0.861638673203922
CALCB,Calcitonin gene-related peptide 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,Inverse variance weighted,9,0.91 [0.70-1.17],0.453219861490261
CALCB,Calcitonin gene-related peptide 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,Inverse variance weighted,9,0.99 [0.79-1.25],0.960674976731525
CALCB,Calcitonin gene-related peptide 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,Inverse variance weighted,9,1.05 [0.75-1.48],0.764875014065646
CALCB,Calcitonin gene-related peptide 2,Chapter VI Diseases of the nervous system,Falls/tendency to fall,Inverse variance weighted,9,0.93 [0.87-0.99],0.0238196005283469
CALCB,Calcitonin gene-related peptide 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",Inverse variance weighted,9,0.88 [0.65-1.20],0.410839703247335
CALCB,Calcitonin gene-related peptide 2,Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,Inverse variance weighted,9,0.92 [0.52-1.63],0.767514308316647
CALCB,Calcitonin gene-related peptide 2,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,Inverse variance weighted,9,0.83 [0.61-1.14],0.259743243662633
CALCB,Calcitonin gene-related peptide 2,Chapter IX Diseases of the circulatory system,"Heart failure, strict",Inverse variance weighted,9,0.94 [0.84-1.05],0.278189015826011
CALCB,Calcitonin gene-related peptide 2,Chapter IX Diseases of the circulatory system,Hypotension,Inverse variance weighted,9,1.11 [0.86-1.43],0.423253350410879
CALCB,Calcitonin gene-related peptide 2,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",Inverse variance weighted,9,1.15 [0.32-4.16],0.835483984667075
CALCB,Calcitonin gene-related peptide 2,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,Inverse variance weighted,9,0.75 [0.45-1.26],0.27817508242372
CALCB,Calcitonin gene-related peptide 2,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,Inverse variance weighted,9,1.20 [0.79-1.83],0.393688742761018
CALCB,Calcitonin gene-related peptide 2,Chapter IX Diseases of the circulatory system,Secondary right heart disease,Inverse variance weighted,9,0.85 [0.51-1.40],0.514672529017396
CALCB,Calcitonin gene-related peptide 2,Chapter X Diseases of the respiratory system,Influenza and pneumonia,Inverse variance weighted,9,0.99 [0.92-1.07],0.834151031471243
CALCB,Calcitonin gene-related peptide 2,Chapter X Diseases of the respiratory system,Other diseases of pleura,Inverse variance weighted,9,0.96 [0.84-1.10],0.531093687715974
CALCB,Calcitonin gene-related peptide 2,Chapter X Diseases of the respiratory system,Pleural effusion,Inverse variance weighted,9,1.01 [0.79-1.28],0.952590880780563
CALCB,Calcitonin gene-related peptide 2,Chapter X Diseases of the respiratory system,Pulmonary oedema,Inverse variance weighted,9,0.73 [0.35-1.55],0.417336631907221
CALCB,Calcitonin gene-related peptide 2,Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,Inverse variance weighted,9,0.67 [0.37-1.18],0.164074133123094
CALCB,Calcitonin gene-related peptide 2,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",Inverse variance weighted,9,0.75 [0.55-1.03],0.0745119834820982
CALCB,Calcitonin gene-related peptide 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,Inverse variance weighted,9,0.81 [0.67-0.98],0.0321917267468634
CALCB,Calcitonin gene-related peptide 2,Chapter XIV Diseases of the genitourinary system,Acute renal failure,Inverse variance weighted,9,0.99 [0.80-1.22],0.903475196436661
CALCB,Calcitonin gene-related peptide 2,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,Inverse variance weighted,9,0.83 [0.51-1.35],0.454765801492726
CALCB,Calcitonin gene-related peptide 2,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,Inverse variance weighted,9,1.02 [0.86-1.22],0.803593002155647
CALCB,Calcitonin gene-related peptide 2,Chapter XIV Diseases of the genitourinary system,Dialysis,Inverse variance weighted,9,0.75 [0.44-1.26],0.277201473471669
CALCB,Calcitonin gene-related peptide 2,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,Inverse variance weighted,9,1.14 [0.85-1.54],0.375515834056123
CALCB,Calcitonin gene-related peptide 2,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,Inverse variance weighted,9,0.99 [0.75-1.30],0.93578589668732
CALCB,Calcitonin gene-related peptide 2,Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,Inverse variance weighted,9,1.20 [0.64-2.24],0.572794830363969
CALCB,Calcitonin gene-related peptide 2,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,Inverse variance weighted,9,1.03 [0.94-1.13],0.483963810024774
CALCB,Calcitonin gene-related peptide 2,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,Inverse variance weighted,9,1.01 [0.73-1.40],0.950179280028443
